$25.5 billion in COVID-19 relief funds to help health care providers hit by the pandemic.

This Weekly’s Hot Topics

  •  TOMORROW, September 22, live webinar on Prostate Cancer Awareness. MOASC News/MOASC Programs
  • September 23, 2021, webinar on challenges of the most pressing issues facing medical practices California News
  • $25.5 billion in COVID-19 relief funds to help health care providers hit by the pandemic. National News
  • Some 340B hospitals charging insurers an average of 3.8 times more than acquisition costs for oncology drugs. National News

California oncology groups and supporters have succeeded in moving SB 310 (Rubio) through the legislature. The bill ensures patients’ access to needed anti-cancer medications.  The bill will create a program that allows oncologists to accept unused, unneeded, medication from their patients and redistribute that medication to other patients in need. To read more click here and go to California News.

Help CMS Improve Provider Resources by taking this confidential Medicare survey. asking about information and resources you use to understand the Medicare program and/or help you bill correctly. AIHC is an educational partner with CMS and asks you to take a few minutes to complete an important Medicare billing survey from CMS. To read more click here and go to Medicare News/CMS news.

HHS will distribute $25.5 billion in COVID-19 relief funds from the American Rescue Plan to help hospitals and other health care providers hit by the pandemic, following pressure from lawmakers and medical groups. About $17 billion will be set aside for applicants who can demonstrate pandemic-related revenue losses, while $8.5 billion will go to those in rural areas. To read more click here and go to National News.

On October 4, 1-2pm PDT, ASH is hosting the final of their new series titled the ASH Advocacy Webinar Series, Working with Advocacy Groups and Coalitions: How to Amplify Your Voice in Washington. ASH is committed to educating its members on how to become effective advocates for hematology research and practice. Registration is free and open to all interested. To read more click here and go to Affiliate Association News/ASH News.

To read the complete the California Oncology Weekly Newsletter, click on the date below.

September 21, 2021 

 

This Weekly’s Hot Topics

  •  National Preparedness Month promotes emergency preparedness and planning National News
  •  White House pushing Congress to focus on reliability of US pharmaceutical supply chains. National News
  •  Congress continues debating the best approach to address prescription drug reform National News
  •  COA Warns Congress of Eroding Cancer Care Infrastructure and Misguided Legislative Proposals. Affiliate Association News/COA News

MOASC greatly appreciates the members who have renewed their support for 2021-2021.
May & June: Cancer and Blood Care Specialists;   Cancer and Blood Specialty Clinic; Cancer Care Institute;   Howard H. Cheng, MD & Associates, LLC;  Coast Hematology Oncology Associates, Inc; Compassionate Oncology Care; Global Oncology Inc.; Daniel R. Lewis, MD; Raghu Nandan, MD, Inc.; Ranjan K. Sapra, MD; Carlos Say, MD; South County Hematology Oncology, Inc.
July & August: James Berenson, MD; California Cancer Associates for Research & Excellence (CCARE); City of Hope; Comprehensive Blood and Cancer Center; Hematology Oncology Consultants; William  H. Isacoff, MD, Inc.; Wellness Oncology & Hematology.
September: Cancer Center Oncology Medical Group. To read more click here and go to MOASC News.

On September 22, 5:30-6:30pm PDT, MOASC will host a live webinar on Prostate Cancer Awareness, with panel discussions on initial treatment of Metastatic Castration Sensitive Prostate Cancer/Increase in newly diagnosed; current thoughts on radiation for primary tumor in Metastatic Disease and new treatments in Castration Resistance Disease in conjunction with genomic testing/PARP inhibitors presented by: Ashkan Lashkari, M.D., MOASC President; Christopher DeSantis, California Urological Association; John Lam, M.D., Kaiser Permanente, Los Angeles; Nataliya Mar, M.D., Assistant Professor, UCI and Steven N. Seyedin, M.D., Assistant Clinical Professor, UCI. This event is complementary but registration is required. To read more click here and go to MOASC News/MOASC Programs.

The California Department of Managed Health Care (DMHC) protects the health care rights of more than 27.7 million Californians and ensures a stable health care delivery system. The Department has helped more than 2.5 million Californians resolve health plan problems through the Help Center. To read more click here and go to California News.

As Congress continues debating the best approach to address prescription drug reform, it is more critical than ever that patient voices are heard. Calls to repeal the non-interference (NI) provision in Medicare Part D are increasing, and it is vital that policymakers understand the negative impact this policy can have on the patients that you represent. To read more click here and go to National News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

September 14, 2021. 

 

September is a multicolored ribbon month. MOASC encourages your support of these agencies and your continued fight against: Childhood cancer, Uterine cancer, Leukemia, Lymphoma, Ovarian cancer, Prostate cancer and Thyroid cancer. Please continue to read the California Oncology Weekly and, this month, plan to attend and participate in the meetings and programs presented for you on these disease types. Thank you.

This Weekly’s Hot Topics

 

  • YOUR ACTION IS NEEDED NOW! Avert a combined 9.75% cut in the Medicare physician payment system. National News
  • TOMORROW! September 8, Enhancing Personalized Medicine in Advanced Ovarian Cancer MOASC News/ MOASC Programs
  • September 11, Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myelomas 2021 ANCO News
  • September 13, comments due for CMS’ proposed rule on the Medicare Physician Fee Schedule (PFS) updates for calendar year (CY) 2022 Medicare News/CMS News
  • September 14, comments due for ICER assessment of the comparative clinical effectiveness and value of plinabulin and trilaciclib for the prevention of chemotherapy-induced neutropenia. National News

Never fight an insurance company again! Impiricus is a new platform for oncologists to access resources and get patients on therapy. Get access to grants, samples, information and more. Submit prior authorization and patient assistance requests in under 30 seconds with Impiricus’ digital interface. To read more click here and go to MOASC News.

In recognition of Ovarian Cancer Awareness Month, MOASC, in collaboration with PeerView, presents a virtual conference on Enhancing Personalized Medicine in Advanced Ovarian Cancer. Listen to expert guidance on integrating the latest updates on PARP inhibitors and novel therapeutic innovations into your clinical practice. To read more click here and go to MOASC News/MOASC Programs.

September 14, 2021, 2pm PDT is the deadline for comments to the Institute for Clinical and Economic Review (ICER) assessment of the comparative clinical effectiveness and value of plinabulin (BeyondSpring Pharmaceuticals) and trilaciclib (Cosela™, G1 Therapeutics) for the prevention of chemotherapy-induced neutropenia. Beyond Spring Pharmaceuticals announced the submission of a New Drug Application (NDA) for plinabulin, and the FDA is expected to respond by late 2021. To read more click here and go to National News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

September 7, 2021

This Weekly’s Hot Topics

  • California Supreme Court issues decision for physicians to challenge peer review hearing officers. California News
  • CMA seeking physicians to help shape regulation implementing Assembly Bill 890 California News
  • 2020 MIPS performance feedback for the period is now available Medicare News/CMS News
  • Ask your Congressional representatives to cosponsor H.R. 3258 National News
  • ICER to assess the comparative clinical effectiveness and value of plinabulin and trilaciclib for the prevention of chemotherapy-induced neutropenia National News
  • UC Davis is conducting a Medical Oncologist Survey ANCO News

The California Supreme Court recently issued an important decision that clarifies a physician’s ability to challenge peer review hearing officers for impermissible bias. CMA filed an amicus brief in the case, in support of neither party, that sought to provide the court with the appropriate background, procedural understanding, and evidentiary foundation to fashion a robust, clear, and contextualized hearing officer impartiality standard. To read more click here and go to California News.

CMA is asking physicians to lend their voices to help shape the regulations implementing Assembly Bill 890 (Wood), which became law on January 1, 2021, and authorizes two new types of nurse practitioners. AB 890 recognized and authorized California nurse practitioners (NPs) to practice at the top of their competence without physician supervision and with a defined scope of practice. To read more click here and go to California News.

Merit-based Incentive Payment System (MIPS) performance feedback, including scores and payment adjustment information, for the 2020 performance period is now available for review on the Medicare Quality Payment Program (QPP) website. The 2020 MIPS scores will determine whether a physician will receive an incentive, neutral payment adjustment or a penalty for Medicare services in the 2022 payment year. To read more click here and go to Medicare News/CMS News.

The push is still on! Ask your Congressional representatives to cosponsor H.R. 3258! The Timely Access to Cancer Treatment Act of 2021 (TACT Act) was recently introduced and still needs congress’ attention. To read more click here and go to National News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

August 31, 2021